<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2019 (7) TMI 862 - ITAT MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=383166</link>
    <description>The Tribunal upheld the CIT(A)&#039;s decision to allow sales promotion expenses for articles costing less than Rs. 750 each and disallow expenses exceeding Rs. 750 per article. The Tribunal dismissed the revenue&#039;s appeal, directing the AO to delete the addition sustained by the CIT(A). It held that MCI regulations and the CBDT circular did not apply to pharmaceutical companies, allowing the expenses under Section 37(1) of the Income-tax Act, 1961.</description>
    <language>en-us</language>
    <pubDate>Fri, 28 Jun 2019 00:00:00 +0530</pubDate>
    <lastBuildDate>Wed, 17 Jul 2019 16:17:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=579828" rel="self" type="application/rss+xml"/>
    <item>
      <title>2019 (7) TMI 862 - ITAT MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=383166</link>
      <description>The Tribunal upheld the CIT(A)&#039;s decision to allow sales promotion expenses for articles costing less than Rs. 750 each and disallow expenses exceeding Rs. 750 per article. The Tribunal dismissed the revenue&#039;s appeal, directing the AO to delete the addition sustained by the CIT(A). It held that MCI regulations and the CBDT circular did not apply to pharmaceutical companies, allowing the expenses under Section 37(1) of the Income-tax Act, 1961.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Fri, 28 Jun 2019 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=383166</guid>
    </item>
  </channel>
</rss>